What are the best ways to manage side effects associated with EGFR and ALK inhibitors?
Beth Eaby-Sandy, MSN, CRNP, OCN, and Elizabeth Waxman, RN, MSN, AOCN, ANP-BC
Beth Eaby-Sandy, MSN, CRNP, OCN, and Elizabeth Waxman, RN, MSN, AOCN, ANP-BC, on advances in targeted treatments for non–small cell lung cancer.